Status:
COMPLETED
Validation of the MBI-C Scale in French
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Subjective Cognitive Complaint
Mild Cognitive Impairment
Eligibility:
All Genders
50+ years
Brief Summary
This study aims to validate the French version of the Mild Behavioral Impairment-Checklist (MBI-C) scale, hypothetically effective for measuring behavioral symptoms in patients presenting with a subje...
Detailed Description
Neuropsychiatric symptoms are common in the prodromal stage of dementia and may precede cognitive impairment. Their presence in patients without cognitive impairment, but with a subjective cognitive c...
Eligibility Criteria
Inclusion
- Patient presenting a subjective cognitive complaint (SCP) or mild cognitive impairment (MCI) for at least 6 months.
- Patient with a relative visiting them at least once a week.
- No opposition from the patient and his loved one
Exclusion
- Patient presenting criteria for major neurocognitive disorder according to DSM-V criteria.
- Neuropsychiatric symptoms secondary to concomitant treatments, or to a medical or psychiatric pathology.
- Concomitant major depressive episode (DSM-V).
- Presence of concomitant pathologies preventing participation in the study (taking tests).
Key Trial Info
Start Date :
June 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 17 2024
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06516159
Start Date
June 26 2023
End Date
October 17 2024
Last Update
April 10 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Limoges
Limoges, France, 87042
2
University Hospital Nice
Nice, France, 06100
3
University Hospital Strasbourg
Strasbourg, France, 67091
4
University Hospital Toulouse
Toulouse, France, 31059